Leukemia, Myeloid
Showing 6126 - 6150 of 6,958
Leukemia Trial in New York (biological, drug, procedure)
Completed
- Leukemia
- aldesleukin
- +6 more
-
New York, New YorkHerbert Irving Comprehensive Cancer Center at Columbia Universit
Feb 1, 2013
T-cell Acute Lymphoblastic Leukemia Trial in Orebro
Completed
- T-cell Acute Lymphoblastic Leukemia
-
Orebro, Orebro county, SwedenOrebro University Hospital
Sep 21, 2013
Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumors Trial in Tucson, Stanford, Houston (bevacizumab)
Completed
- Leukemia
- +2 more
- bevacizumab
-
Tucson, Arizona
- +2 more
May 14, 2013
Leukemia Trial in Austria, Germany (alemtuzumab)
Completed
- Leukemia
- alemtuzumab
-
Vienna, Austria
- +34 more
Nov 5, 2013
Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in Houston (decitabine, romidepsin)
Completed
- Chronic Myeloproliferative Disorders
- +3 more
-
Houston, TexasM.D. Anderson Cancer Center at University of Texas
Feb 8, 2013
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Tokyo (procedure, radiation,
Completed
- Acute Myelogenous Leukemia
- +3 more
- Cord blood transplantation
- +3 more
-
Tokyo, JapanKeio University School of Medicine
Apr 5, 2012
Leukemia, Neutropenia Trial in Rome (biological, drug, procedure)
Completed
- Leukemia
- Neutropenia
- filgrastim
- +7 more
-
Rome, ItalyAzienda Policlinico Umberto Primo
Jun 29, 2012
Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumors Trial in Seoul (biological, drug, procedure)
Completed
- Leukemia
- +2 more
- anti-thymocyte globulin
- +7 more
-
Seoul, Korea, Republic ofAsan Medical Center - University of Ulsan College of Medicine
Mar 25, 2013
Myelodysplastic Syndrome, Acute Myelogenous Leukemia Trial in Stockholm (Azacitidine, azacitidine + lenalidomide)
Unknown status
- Myelodysplastic Syndrome
- Acute Myelogenous Leukemia
- Azacitidine
- azacitidine + lenalidomide
-
Stockholm, SwedenLars Möllgård
Mar 14, 2012
Cancer Trial in Dajeon, Seoul (therapeutic allogeneic lymphocytes)
Completed
- Cancer
- therapeutic allogeneic lymphocytes
-
Dajeon, Korea, Republic of
- +1 more
Mar 25, 2013
Patient Acceptance of Treatment With MabCampath in Chronic
Terminated
- Chronic Lymphocytic Leukemia
- Alemtuzumab (MabCampath)
-
Many Locations, Bosnia and Herzegovina
- +2 more
Dec 2, 2013
Leukemia, MDS Trial in Worldwide (clofarabine, cytarabine, idarubicin)
Unknown status
- Leukemia
- Myelodysplastic Syndromes
- clofarabine
- +2 more
-
Brugge, Belgium
- +9 more
Jul 19, 2012
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Seoul (biological, drug, procedure)
Completed
- Leukemia
- +5 more
- anti-thymocyte globulin
- +7 more
-
Seoul, Korea, Republic ofAsan Medical Center - University of Ulsan College of Medicine
Mar 25, 2013
Quality of Life of Adult Cancer Survivors Who Have
Completed
- Leukemia
- +3 more
- cognitive assessment
- +3 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Apr 29, 2013
Healthy Male Subjects Trial in Arzo (Filgrastim test, Filgrastim reference)
Completed
- Healthy Male Subjects
- Filgrastim test
- Filgrastim reference
-
Arzo, Ticino, SwitzerlandCROSS Research SA
Sep 6, 2013
Leukemia, MDS Trial in Portland, Seattle (fludarabine, treosulfan, allogeneic blood or bone marrow transplantation)
Completed
- Leukemia
- Myelodysplastic Syndromes
- fludarabine
- +2 more
-
Portland, Oregon
- +2 more
May 24, 2012
Cardiac Toxicity, Lymphoma Trial in Australia, Canada, United States (biological, drug, radiation)
Completed
- Cardiac Toxicity
- Lymphoma
- bleomycin sulfate
- +8 more
-
Long Beach, California
- +38 more
Aug 22, 2013
Leukemia Trial in Houston (Busulfan, Fludarabine)
Completed
- Leukemia
-
Houston, TexasU.T.M.D. Anderson Cancer Center
May 23, 2012
XCL1 as a Prognostic Marker in Acute Lymphoblastic Leukemia
Completed
- Acute Lymphoblastic Leukemia
-
Monterrey, Nuevo Leon, MexicoHospital Universitario Dr. Jose E. Gonzalez UANL
Aug 26, 2013
GVHD, Leukemia, MDS Trial in New York (busulfan, melphalan, methotrexate)
Completed
- Graft Versus Host Disease
- +3 more
- busulfan
- +4 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Mar 6, 2013
B-cell Chronic Lymphocytic Leukemia, Leukemia, Prolymphocytic Leukemia Trial in Boston (drug, biological, other)
Terminated
- B-cell Chronic Lymphocytic Leukemia
- +7 more
- obatoclax mesylate
- +3 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Sep 27, 2013
Relapsed Acute Promyelocytic Leukemia Trial in Vellore (Bortezomib)
Unknown status
- Relapsed Acute Promyelocytic Leukemia
-
Vellore, TN, IndiaDepartment of Haematology, Christian Medical College
Sep 24, 2013